Your First 100 for Medical Practices & Entrepreneurs
You understand the science. But do you understand the stock? As a healthcare professional, you already have an edge most investors can never buy — you can read clinical literature, evaluate treatment efficacy, and spot genuine medical breakthroughs. The missing piece? The financial framework to turn that expertise into smarter investing decisions. In this episode, I sit down with Bryant Burciaga — former buy-side equity research analyst turned consultant — to help healthcare providers bridge the gap between scientific fluency and financial literacy. We cover: * How to build and interpret financial models for biotech and healthcare equities * The key catalysts that drive stock movement in this sector * Red flags that signal a biotech company is in financial distress * Where to find analyst reports — and how to understand what's already priced into the market For anyone that wanted to translate their scientific knowledge into healthcare/biotech investing, this is a can't miss episode! Your knowledge of medicine is your moat. This episode helps you use it!
22 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Your First 100 for Medical Practices & Entrepreneurs!